DealsGED-backed Vitro exits CytognosVitro, which is backed by GED Capital, has sold Cytognos to Becton Dickinson.ByIris Dorbian3 February 2022•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs